BioSpace News Archive

LAVA Therapeutics N.V. announced the Annual General Meeting of Shareholders will take place on Wednesday, June 15, 2022, at 7:30 a.m. CEST, at Beethovenstraat 400, 1082 PR, Amsterdam, the Netherlands.

According to Vision Research Reports, the Non-invasive Aesthetic Treatment market size is expected to be worth around US$ 150 billion by 2030 from valued at US$ 49 billion in 2020 and growing at a CAGR of 15.7% from 2021 to 2030.

ChemoCentryx, Inc., (Nasdaq: CCXI), today announced upcoming abstract presentations at three key medical conferences taking place in June, which highlight TAVNEOS® (avacopan).

Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, today announced that it will host an investor event during the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting.

Concert Pharmaceuticals, Inc. announced that it intends to offer and sell 10,000,000 shares of its common stock in an underwritten registered public offering.

Arcus Biosciences (NYSE:RCUS), announced that its management team will participate in a fireside chat at the upcoming Goldman Sachs 43rd Annual Global Healthcare Conference at the Terranea Resort in Rancho Palos Verdes, California.

Exelixis, Inc. announced that members of the company’s management team will participate in fireside chats at the following investor conferences in June.

Estimates are that around one in 10 adult Americans are diabetic, and the majority of them are among the 24 million plus that have Type 2 diabetes and are insulin resistant.

Greenfire Bio, LLC announced today that its subsidiary, Green3Bio, and its collaborators at MD Anderson Cancer Center will present an update on the ongoing first-in-human clinical trial of GRN-300 at the upcoming ASCO 2022 Annual Meeting.

Quadrant Biosciences Inc., a developer of novel molecular diagnostics, announced that Dr. Funda Suer has joined the company as Executive Vice President of Clinical Diagnostics and CLIA Laboratory Director.